神经科学通报(英文版)2023,Vol.39Issue(10) :1497-1511.DOI:10.1007/s12264-023-01068-z

Compound from Magnolia officinalis Ameliorates White Matter Injury by Promoting Oligodendrocyte Maturation in Chronic Cerebral Ischemia Models

Zhi Zhang Xin Shu Qian Cao Lushan Xu Zibu Wang Chenggang Li Shengnan Xia Pengfei Shao Xinyu Bao Liang Sun Yuhao Xu Yun Xu
神经科学通报(英文版)2023,Vol.39Issue(10) :1497-1511.DOI:10.1007/s12264-023-01068-z

Compound from Magnolia officinalis Ameliorates White Matter Injury by Promoting Oligodendrocyte Maturation in Chronic Cerebral Ischemia Models

Zhi Zhang 1Xin Shu 1Qian Cao 1Lushan Xu 1Zibu Wang 1Chenggang Li 1Shengnan Xia 2Pengfei Shao 2Xinyu Bao 2Liang Sun 1Yuhao Xu 2Yun Xu3
扫码查看

作者信息

  • 1. Department of Neurology,Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210008,China;Department of Neurology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School and State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases,Nanjing University,Nanjing 210008,China
  • 2. Department of Neurology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School and State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases,Nanjing University,Nanjing 210008,China;Jiangsu Key Laboratory for Molecular Medicine,Medical School of Nanjing University,Nanjing 210008,China
  • 3. Department of Neurology,Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210008,China;Department of Neurology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School and State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases,Nanjing University,Nanjing 210008,China;Jiangsu Key Laboratory for Molecular Medicine,Medical School of Nanjing University,N
  • 折叠

Abstract

Chronic cerebral hypoperfusion leads to white matter injury(WMI),which subsequently causes neurode-generation and even cognitive impairment.However,due to the lack of treatment specifically for WMI,novel recognized and effective therapeutic strategies are urgently needed.In this study,we found that honokiol and magnolol,two com-pounds derived from Magnolia officinalis,significantly facilitated the differentiation of primary oligodendrocyte precursor cells(OPCs)into mature oligodendrocytes,with a more prominent effect of the former compound.Moreover,our results demonstrated that honokiol treatment improved myelin injury,induced mature oligodendrocyte protein expression,attenuated cognitive decline,promoted oligoden-drocyte regeneration,and inhibited astrocytic activation in the bilateral carotid artery stenosis model.Mechanistically,honokiol increased the phosphorylation of serine/threonine kinase(Akt)and mammalian target of rapamycin(mTOR)by activating cannabinoid receptor 1 during OPC differentia-tion.Collectively,our study indicates that honokiol might serve as a potential treatment for WMI in chronic cerebral ischemia.

Key words

Honokiol/White matter injury/Oligodendrocyte/Vascular dementia

引用本文复制引用

基金项目

National Natural Science Foundation of China(81920108017)

National Natural Science Foundation of China(82130036)

Key Research and Development Program of Jiangsu Province of China(BE2020620)

Jiangsu Province Key Medical Discipline(ZDXKA2016020)

出版年

2023
神经科学通报(英文版)
中国科学院上海生命科学研究院

神经科学通报(英文版)

CSTPCDCSCD
影响因子:0.741
ISSN:1673-7067
参考文献量1
段落导航相关论文